What is Celoxica?
Celoxica specializes in delivering comprehensive ultra-low latency (ULL) trading solutions designed for both buy-side and sell-side clients across diverse asset classes. Their offerings encompass pre-trade risk management, order execution, and market data solutions, all aimed at optimizing trading environments for hedge funds, banks, and proprietary trading firms. The company is recognized for its capacity to provide fast, compliant, and robust trading services, thereby enhancing clients' trading strategies and operational efficiency. With a global footprint supporting over 60 exchanges, Celoxica is dedicated to offering superior service and performance within the trading community. Key funding terms include capital, investment, and financing.
How much funding has Celoxica raised?
Celoxica has raised a total of $61.4M across 8 funding rounds:
Other Financing Round
$11.3M
Other Financing Round
$5.8M
Other Financing Round
$4M
Other Financing Round
$1.7M
Other Financing Round
$5.1M
Other Financing Round
$1M
Unspecified
$2.4M
Other Financing Round (2005): $11.3M led by Herald Ventures, Quester, Oxford Capital Partners, and Invesco
Other Financing Round (2007): $5.8M supported by Invesco, XILINX, Oxford Capital Partners, Advent Venture Partners, Quest Capital, and Herald Ventures
Other Financing Round (2008): $4M featuring Spark Ventures, Oxford Capital Partners, and Herald Ventures
Other Financing Round (2010): $1.7M backed by Oxford Capital Partners, Credit Suisse, Spark Ventures, and Herald Ventures
Other Financing Round (2011): $5.1M with participation from Credit Suisse, Oxford Capital Partners, and Goldman Sachs
Other Financing Round (2012): $1M led by Goldman Sachs, Spark Ventures, Credit Suisse, Oxford Capital Partners, and Herald Ventures
Unspecified (2014): $2.4M, investors not publicly disclosed
Key Investors in Celoxica
Credit Suisse
Credit Suisse is a global investment bank providing a wide range of financial services, including advisory, underwriting, and asset management, playing a significant role in capital markets.
Oxford Capital Partners
Oxford Capital Partners is an investment manager providing growth capital to smaller companies across various industries, aiming to help entrepreneurs scale their businesses.
Herald Ventures
Herald Ventures specializes in capital growth through investments in technology, media, and communications sectors, managing both public and private funds.
What's next for Celoxica?
The substantial enterprise-level funding and recent strategic investment indicate Celoxica is in a scaling phase, likely focusing on expanding its market reach, enhancing its technological infrastructure, and potentially exploring new asset classes or regulatory compliance solutions. This capital infusion will empower the company to further solidify its position in the competitive ULL trading solutions market, driving innovation and supporting its global client base. The company's trajectory suggests a continued focus on performance and efficiency in financial markets.
See full Celoxica company page
